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What is already known on this topic? 
• Low birth weight and rapid catch-up in infancy and early childhood are associated with 
increased cardiovascular risk in later life in general populations. 
• Evidence is limited and mixed on the long-term health effects of the growth trajectory from 
birth to full-term age in preterm infants. 
• Greater catch-up in weight in childhood is shown in populations born preterm, but whether 
this put them at increased cardiometabolic risk deserves more research. 
What this study adds? 
• No associations of size at extremely preterm birth with the presence of metabolic syndrome, 
BMI or central SBP in early adulthood were found.  
• An inverse relationship between size at extremely preterm birth and BMI in early adulthood 
was found in the lower socioeconomic status group.  
• Increased catch-up in weight from 2.5-6 years (not in preterm period nor in infancy) was 




Objectives:  To investigate whether size at birth and growth trajectories in infancy and childhood are 
associated with determinants of cardiovascular and metabolic risk in young adults born extremely 
preterm (EP; <26 weeks of gestation). 
Methods: We used longitudinal data from the EPICure study of 129 EP survivors up to 19 years in the 
UK and Ireland in 1995. Determinants of cardiovascular and metabolic risk at 19 years included the 
presence of metabolic syndrome, BMI, and systolic blood pressure (SBP). Predictors were birth weight 
for gestation and gain in weight z-scores in the following periods: birth to 40 weeks postmenstrual age 
(term), infancy (term to 2.5 years), early childhood (2.5-6 years) and late childhood (6-11 years). 
Results: Metabolic syndrome was present in 8.7% of EP participants at 19 years. Compared to 
subjects without, those with metabolic syndrome tended to have a smaller size at birth (difference 
in means: -0.55 SD, 95% CI: -1.10 to 0.01, p=0.053) and a greater increase in weight z-scores from 
term to 2.5 years (difference in means: 1.00 SD (-0.17 to 2.17), p=0.094). BMI at 19 years was 
positively related to growth from 2.5-6 years (𝛽: 1.03 (0.31, 1.75), p=0.006); an inverse association 
with birthweight z-scores was found in the lower SES group (𝛽: -1.79 (-3.41, -0.17), p=0.031). Central 
SBP was positively related to growth from 2.5-6 years (𝛽: 1.75 (0.48 to 3.02), p=0.007). 
Conclusions: Size at EP birth and increased catch-up in weight from 2.5-6 years were associated with 
BMI and central SBP in early adulthood.  




The relationships between low weight at birth and increased risk in later life of adiposity, 
cardiovascular disease and type 2 diabetes (T2DM) are well established in general populations 1-8. 
Higher risk is thought to be a consequence of persisting physiological and metabolic changes that 
accompany slow intrauterine growth. However, many of the early epidemiological studies had very 
limited data on gestational age. In the general population, low weight at birth can result from both 
fetal growth restriction and preterm birth. Advances in perinatal and neonatal care in the 1990s 
were associated with greatly improved survival of very preterm babies, which, together with 
enhanced accuracy in gestational age estimation, have made it possible to examine influences on 
childhood growth and cardiometabolic risk in early adult life.  
We have previously shown that, compared to birth at term, fetal growth in extremely preterm 
survivors (EP; <26 weeks of gestation) has a slower trajectory from birth to full-term age, leading to 
an appreciable decrease in weight z-scores. Catch-up in weight only commences after reaching term 
age9. This is in line with reports from other cohort studies in the UK, Sweden and the Netherlands10-
13. Evidence has been limited and mixed on the long-term health effects of this growth trajectory in 
preterm infants. Some studies indicate that a greater weight gain during the period from birth to 
term age/discharge has adverse effects on later body composition, obesity and cardiovascular 
health11,13, whilst others reported no effects on the markers of the metabolic syndrome12,14-17.  
We have previously shown greater catch-up in weight in childhood among EP participants than term-
born children18. Weight at birth is lower for preterm births than that expected from fetal growth 
data. There is increased concern that pronounced fetal and postnatal growth restriction, with 
accelerated catch-up growth in childhood, may put these children at increased risk of metabolic and 
cardiovascular morbidity in later life. Repeatedly in babies born at full term, rapid catch-up in infancy 
and early childhood has been associated with increased risk for obesity, hypertension, 
cardiovascular disease and T2DM in adulthood19-25. Evidence linking such factors in populations born 
preterm is less extensive, but data suggest that weight gain in infancy after term age is positively 
related to BMI26, fat mass or percentage body fat11,26, insulin level27 and serum levels of total 
cholesterol and low-density lipoprotein (LDL) cholesterol11, and borderline related to high-density 
lipoprotein (HDL) cholesterol level 11. There is also some evidence showing accelerated postnatal 
growth during the first months after birth did not affect systolic blood pressure (SBP) at 19 years in 
individuals who were born preterm, but those who showed increased postnatal weight gain and BMI 
after 5 years had higher SBP28.  
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We used longitudinal data from the EPICure study of 129 EP survivors up to 19 years to investigate 
whether size at birth and growth trajectories in preterm period (birth to term age defined as 40 
weeks postmenstrual age), infancy (term-2.5 years), early childhood (2.5-6 years) and late childhood 
(6-11 years) were associated with determinants of metabolic and cardiovascular risk at age 19 years. 
We hypothesised that following EP birth, size at birth and growth in infancy and childhood, but not 
growth in the preterm period, would be associated with determinants of cardiovascular and 
metabolic risk in early adult life. 
METHODS 
Subjects 
The EPICure study comprised 315 infants born at 25 completed weeks of gestation or less in all 276 
maternity units in the UK and Ireland from March to December 1995 who were discharged alive 
from neonatal intensive care units. Recruitment of the cohort has been described in detail 
previously29-31. The survivors were followed longitudinally at age 2.5, 6, 11 and 19 years. A flow chart 
detailing dropout has been published previously32. Nine deaths occurred between discharge and the 
19-year assessment, at which 129 (42%) of EP participants were assessed. At 6 years, 160 term-born 
classmates (≥37 weeks of gestation) were recruited for 204 children attending mainstream schools. 
They were matched on age, sex and ethnicity. At 11 years, 110 of them were re-assessed and 43 new 
controls were recruited. At 19 years, 65 of those attending at 11 years were re-assessed. Each follow 
up assessment was approved by the ethics committee. Written informed consent was provided by 
parents up to 11 years and by individual participants at 19 years. The assessment at 19 years was 
approved by the South Central Hampshire A Research Ethics Committee (Ref: 13/SC/0514). 
Measures 
Growth, cardiovascular evaluations and other risk factors at age 19 years have been described 
previously (Hurst et al. 2020, in press). The prevalence of metabolic syndrome was calculated, based 
on the criteria defined by the International Diabetes Federation as having central obesity measured 
by waist circumference or BMI, together with any two of the following components: (1) raised 
triglycerides; (2) reduced HDL cholesterol; (3) raised blood pressure; and (4) raised fasting plasma 
glucose33.  
Explanatory variables of interest included birth weight and changes in (∆) weight z-scores during the 
following periods: birth to term, infancy (term-2.5 years), early childhood (2.5-6 years), and late 
childhood (6-11 years). Growth data were collected at each age, which have been described in detail 
previously 9,15.  Only weight was collected at birth and term age. Standard deviation scores (z-scores) 
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for weight were calculated at each age based on UK population norms34. Birthweight z-scores (birth 
weight for gestation) were derived from the complete birth population29. 
Data on confounding factors were obtained from the main study. These included sex (males vs 
females), gestational age, multiple births (yes vs no), ethnicity (white vs non-white), maternal age, 
maternal education (A level or above vs GCSE or below), maternal smoking during pregnancy (yes vs 
no) and socioeconomic status (SES), which was based on parental occupational status at 2.5 years 
and dichotomised as (1) higher: non-manual employment; (2) lower: including those in manual 
employment or unemployed.  
Statistical Analyses 
Factors related to the presence of metabolic syndrome (yes vs no) at 19 years were explored using 
two sample t-tests or chi-square tests. Multivariate linear regression was used to examine 
associations of birthweight z-score with BMI and central SBP at age 19 years (two determinants of 
cardiovascular and metabolic risk). Univariate linear regression was used to screen for confounders. 
For a potential confounder to be retained in the final models, it was required to have a p value 
<0.10. Interactions of birthweight z-score and confounders were tested. Confounding factors in the 
final models included sex, maternal age and maternal smoking during pregnancy. Similar strategies 
were followed when examining the impacts of growth patterns in infancy and childhood. All analyses 
were performed using STATA 15.1. Correction for multiple comparisons was applied using the 
Benjamini-Hochberg procedure to control for the false discovery rate 35. There was a small amount 
of missing data in BMI (0.01%) and central SBP (0.03%) measured at 19 years and they were 
excluded from the analysis. This is unlikely to influence the results due to small numbers.  
RESULTS  
Participants. The mean birth weight (range) for the whole cohort of 315 EP survivors was 747g (423-
1040); 41% were 24 weeks of gestational age or less; 49.2% were males and 25.2% were multiple 
births. Birthweight z-score were derived from the complete birth population29 and were available for 
312 infants (mean -0.18 SD; table 1); among them, 49 (15.7%) had z-scores < -1 SD. Progressive loss 
to follow up occurred for the EPICure study over the period of 19 years, and similar attrition 
occurred in the control group. The cohort included in this analysis were representative of the total 
original cohort in relation to sex, birth weight and gestational age. EP participants at 19 years were 
more likely to be from a multiple pregnancy, have mothers who were older, of white ethnicity and 
with higher educational attainment, and have parents with higher SES (table S1), which has been 
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reported previously32. The anthropometric and clinical characteristics of the participants are shown 
in table 1.  
Early growth and cardiovascular and metabolic risk at 19 years. The prevalence of metabolic 
syndrome was 8.7% for EP participants and 3.7% for controls (p=0.240; table 1). Similar results were 
shown for the five metabolic syndrome components (table 1). EP participants with metabolic 
syndrome tended to have a smaller size at birth (difference in means: -0.55 SD, 95% confidence 
interval: -1.10 to 0.01, p=0.053; table 2) and a higher increase in weight z-scores from term to 2.5y 
(difference in means: 1.00 SD, 95% CI: -0.17 to 2.17, p=0.094).  
Change in (∆) weight z-scores in early childhood from 2.5-6 years was positively related to BMI at 19 
years (𝛽: 1.03 (0.31, 1.75), p=0.006; table 3): an average increase of 1.03 kg/m2 in BMI for per SD 
increase in ∆ weight z-scores from 2.5-6 years; this relationship was independent of size at birth. 
Young adults with BMI >30 kg/m2 had a mean of 1.87 SD in ∆ weight z-scores from 2.5-6 years, 
significantly higher than those with lower BMI (difference in means: 1.54 (0.76, 2.32)). A significant 
interaction was found between SES and birthweight z-score (𝛽: 2.06 (0.01, 4.12), p=0.049). 
Birthweight z-score was not associated with BMI at 19 years (table 3), but after adjusting for the 
interaction between SES and birthweight z-score, the association became significant (𝛽: -1.90 (-3.35, 
-0.45), p=0.011; figure 1). Subgroup analysis showed an inverse association in the lower SES group, 
and this remained significant after adjusting for sex, maternal age and maternal smoking during 
pregnancy (𝛽: -1.79 (-3.41, -0.17), p=0.031), which was not found in the higher SES group (figure S1). 
Growth in other periods was not significantly associated with BMI at 19 years (table 3). Central SBP 
at 19 years was positively associated with ∆ weight z-scores from 2.5-6 years (𝛽: 1.75 (0.48 to 3.02), 
p=0.007; figure 2), but unrelated to size at birth and growth in other periods (table 3). Significant 
findings remained unchanged after adjustment for multiple comparisons. 
DISCUSSION 
Using data from EP survivors born before 26 weeks of gestation in 1995, we show that firstly, 8.7% 
met the criteria for metabolic syndrome and 3.7% of term-born controls. This is similar to a pooled 
analysis reporting a range of 4.8-7.0% in healthy adults aged 18-30 years36. Secondly, we found that 
size at EP birth was not associated with the presence of metabolic syndrome, BMI or central SBP in 
early adulthood, although an inverse relationship with BMI was found in the lower SES group. 
Thirdly, growth during the preterm period from birth to term equivalent age, which is a period 
where growth velocity is frequently poor, was not related to early adult outcomes, in line with most 
previous studies in preterm children12,14-17. In contrast, after term equivalent age, increased weight 
gain from 2.5-6 years was associated with BMI and SBP in early adulthood.  
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Previous studies have reported either no or variable associations between birth weight and 
determinants of cardiovascular and metabolic risk in populations born preterm12,17,26-28.  Here in 
young adults born EP, we did not find that size at birth was associated with cardiovascular and 
metabolic risk. This is not consistent with previous studies in adults born at term37,38 and fails to 
support the fetal origins hypothesis39. Interestingly, an inverse relationship between birth weight for 
gestation and BMI at 19 years was found in the lower SES group. The underlying mechanism is 
unknown. Previous research suggests that low SES, measured by occupational status, was associated 
with increased risk of obesity in women40 and that maternal weight/BMI before pregnancy explains 
the association between birth weight and adult BMI41. We therefore speculate that pre-pregnancy 
weight might mediate this relationship. 
Loss to follow-up was higher among participants with lower SES, so the question arises whether the 
observed association was biased by selective response. Lower SES was neither related to birth 
weight nor outcomes in our study but was associated with greater weight gain from birth to term-
age. Adjusting for confounders and subsequent growth did not change the relationships, which 
makes this less likely. In comparison to birthweight, gestational age was unrelated to any outcome 
(data not shown), indicating that it may not be a good marker for cardiovascular and metabolic risk 
in this group.  
Our data show that EP participants with metabolic syndrome at 19 years tended to have smaller size 
at birth and a higher increase in weight z-scores from term-2.5 years. Previous research has shown 
that weight gain in infancy after term age is positively related to BMI26, fat mass or percentage body 
fat11,26, insulin level27 and serum levels of total cholesterol and LDL cholesterol11. We also show 
positive associations of growth from 2.5-6 years with BMI and central SBP in young adults born EP. 
Despite a lack of evidence from other preterm populations, a Swedish birth cohort study of healthy 
singletons showed rapid weight gain in early childhood (3-6 years) predicted adiposity at 17 years 22, 
but not metabolic syndrome risk 23. We found no relationship between growth from 6-11 years and 
determinants of cardiovascular and metabolic risk, failing to support our hypothesis and in contrast 
to a previous study suggesting that increased postnatal weight gain after age 5 years was a predictor 
for systolic blood pressure at 19 years28. 
The strength of this study lies in the longitudinal design with a long duration of follow-up from birth 
to early adulthood and detailed assessment on cardiovascular and metabolic risk. It allows us to 
explore the effects of size at birth and growth in both early life and throughout childhood in relation 
to determinants of cardiovascular and metabolic risk in early adulthood. Other strengths are 
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adjusting for potential confounders and controlling for the false discovery rate using the Benjamini–
Hochberg procedure to decrease the risk of type I error.  
The study also has limitations. First, although the original cohort encompassed the entire population 
of extremely preterm infants in the UK and Ireland in 1995 who had been discharged alive after 
neonatal intensive care, the number of participants lost to follow-up increased over time and 
dropout was associated with markers of social disadvantage. However, those who participated did 
not differ from the original cohort on baseline characteristics (sex, gestational age and birth weight). 
Second, we have to be cautious to generalise our findings to other populations and they need to be 
confirmed in cohorts from different socioeconomic and cultural settings. We also have to be 
cautious in inferring causality as in any observational study. Lastly, it is possible that some weak 
associations would have reached significance in a larger sample, for instance, the associations of 
birth weight for gestation and the increase in weight z-scores from term-2.5 years with the presence 
of metabolic syndrome at 19 years. 
In conclusion, following EP birth, an inverse relationship between size at birth and BMI in early 
adulthood was only found in the lower SES group, measured by parental occupational status. 
Increased catch-up in weight from 2.5-6 years (not in preterm period nor in infancy) was associated 
with BMI and central SBP in early adulthood, which suggests an opportunity for targeted 
interventions in early childhood to prevent the development of cardiovascular and metabolic risk in 
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Table 1 Characteristics of extremely preterm and control participants  
Variables 
Whole cohort Controls 
N=315  
Perinatal variables    
Male Sex % (n)                     49.2% (155) 38.5% (25) + 
Gestational age    
<=23 weeks  % (n)                     9.2% (29) - 
24 weeks % (n)                     31.7% (100) - 
      25 weeks % (n) 59.0% (186) - 
Multiple births % (n/N)                     25.2% (79/314) - 
White ethnicity % (n)                     76.5% (241) - 
Maternal age Mean (SD) 28.5 (5.9) [n=313] - 
Maternal smoking during pregnancy % (n/N)                     32.9% (93/283) - 
Maternal education (A level or above) a  % (n/N)                     25.9% (68/263) - 
Higher SES a % (n/N)                     31.0% (84/271) - 
Birth weight (kg) Mean (SD) 0.75 (0.11) [n=315] - 
Birthweight z-score Mean (SD) -0.18 (0.76) [n=312] - 
Early growth b    
Weight gain from birth to term (kg) Mean (SD) 1.82 (0.49) [n=284] - 
Change in (∆) z-score from birth to term Mean (SD) -1.50 (1.05) [n=275] - 
Weight gain from term to 2.5y (kg) Mean (SD) 9.3 (1.7) [n=264] - 
∆ z-score from term to 2.5y Mean (SD) 0.07 (1.42) [n=258] - 
Weight gain from 2.5y to 6y (kg) Mean (SD)   6.8 (2.7) [n=226] - 
∆ z-score from 2.5y to 6y Mean (SD) 0.37(1.03) [n=226] - 
Weight gain from 6y to 11y (kg) Mean (SD)  15.6 (6.2) [n=201]  17.4 (7.5) [n=110] 
∆ z-score from 6y to 11y Mean (SD) 0.84 (0.86) [n=201] 0.25 (0.75) [n=110] 
Continuous outcomes at 19 years    
BMI  (kg/m2) Mean (SD)  23.3 (4.4) [n=128] 24.7 ( 5.7) [n=65] 
Waist circumference (cm) Mean (SD)  82.7 (11.4) [n=103]  82.3 (12.8) [n=52] 
Waist-hip ratio Mean (SD)  85.3 (6.3) [n=103]  81.3 ( 5.5) [n=52] 
Seated brachial Systolic BP (mmHg) Mean (SD) 119.5 (10.1) [n=127] 117.9 ( 9.8) [n=64] 
Seated brachial Diastolic BP (mmHg) Mean (SD)  73.2 (7.9) [n=127]  71.6 ( 6.0) [n=64] 
Supine brachial Systolic BP (mmHg) Mean (SD) 119.1 (10.0) [n=127] 116.1 (10.0) [n=64] 
Supine brachial Diastolic BP (mmHg) Mean (SD)  69.4 (7.4) [n=127]  65.9 ( 5.8) [n=64] 
Central Systolic BP (mmHg) Mean (SD) 101.2 (8.0) [n=126]  96.7 ( 7.8) [n=64] 
Central Diastolic BP (mmHg) Mean (SD)  70.6 (7.6) [n=126]  66.9 ( 5.9) [n=64] 
Aortic Augmentation Index (%)  Mean (SD)   6.6 (9.0) [n=126]   0.4 ( 8.2) [n=64] 
Triglycerides (mmol/l) Mean (SD)   0.9 (0.5) [n=109]   0.9 ( 0.4) [n=61] 
HDL (mmol/l) Mean (SD)   1.5 (0.4) [n=109]   1.6 ( 0.4) [n=61] 
LDL (mmol/l) Mean (SD)   2.3 (0.8) [n=109]   2.4 ( 0.7) [n=61] 
Fasting glucose (mmol/l) Mean (SD)   4.9 (0.7) [n=111]   4.9 ( 0.4) [n=60] 
Metabolic syndrome at 19 years c % (n/N)                     8.7% (9/103) 3.7% (2/54) 
Central obesity c % (n/N)                     35.6% (37/104) 35.2% (19/54) 
Raised triglycerides c (>=1.7mmol/l)  % (n/N)                     9.2% (10/109) 6.6% (4/61) 
Raised HDL c % (n/N)                     17.4% (19/109) 11.5% (7/61) 
Raised blood pressure c % (n/N)                     18.1% (23/127) 9.4% (6/64) 
Raised glucose c (>=5.6mmol/l) % (n/N)                     7.2% (8/111) 3.3% (2/60) 
+ Data reported for controls at 19 years. a Maternal education and socioeconomic status (SES) were collected using 
parent questionnaire at age 2.5 years; SES was based on using parent occupation: (1) higher: non-manual employment; 
(2) lower: including those in manual employment or unemployed. b Growth data at 2.5 years: uncorrected for 
prematurity. c Metabolic syndrome was defined by the International Diabetes Federation as having central obesity 
measured by waist circumference or BMI, together with any two of the following components: (1) raised triglycerides; 
(2) reduced HDL cholesterol; (3) raised blood pressure; and (4) raised fasting plasma glucose.
 
 
Table 2 Factors related to the presence of metabolic syndrome at 19 years in young adults born extremely 
preterm+ 
  Metabolic syndrome a    
  No Yes Yes vs No p 
  mean (SD) mean (SD) 
Difference in 
means (95% CI) 
  
Maternal age 29.58 (5.18) [n=92] 27.89 (5.25) [n=9] -1.69 (-5.28, 1.91) 0.354 
Gestational age 24.95 (0.78) [n=94] 24.76 (1.21) [n=9] -0.19 (-0.76, 0.37) 0.500 
Birthweight z-score -0.15 (0.77) [n=92] -0.70 (0.55) [n=8] -0.55 (-1.10, 0.01) 0.053 
Change in (∆) weight z-score from 
birth to term 
-1.59 (1.05) [n=88] -1.51 (1.28) [n=6] 0.08 (-0.81, 0.97) 0.853 
∆ weight z-score from term to 2.5y b  0.11 (1.50) [n=86]  1.11 (1.48) [n=7] 1.00 (-0.17, 2.17) 0.094 
∆ weight z-score from 2.5y to 6y b  0.38 (1.06) [n=87]  0.70 (1.25) [n=9] 0.32 (-0.43, 1.06) 0.403 
∆ weight z-score from 6y to 11y  0.72 (0.82) [n=88]  0.90 (0.68) [n=8] 0.17 (-0.42, 0.77) 0.561 
  Metabolic syndrome a    
  No Yes    
  %(n/N) %(n/N)  p 
Sex     
Female 92.7% (51/55)  7.3% (4/55) - 0.573 
Male 89.6% (43/48) 10.4% (5/48) -  
Gestational age     
<=23 weeks 83.3% (10/12) 16.7% (2/12) - 0.325 
24 weeks 96.8% (30/31)  3.2% (1/31) -  
25 weeks 90.0% (54/60) 10.0% (6/60) -  
Multiple births     
Yes 88.2% (30/34) 11.8% (4/34) - 0.459 
No 92.6% (63/68)  7.4% (5/68) -  
White ethnicity     
Yes 92.9% (79/85)  7.1% (6/85) - 0.190 
No 83.3% (15/18) 16.7% (3/18) -  
Maternal smoking during pregnancy     
Yes 78.6% (22/28) 21.4% (6/28) - 0.005* 
No 96.0% (72/75)  4.0% (3/75) -  
Higher SES c     
Yes 95.5% (42/44)  4.5% (2/44) - 0.227 
No 88.7% (47/53) 11.3% (6/53) -  





Yes  96.2% (25/26)  3.8% (1/26) - 0.340 
No 90.1% (64/71)  9.9% (7/71)   
+ p values were calculated using two sample t-tests or chi-square tests. *Correction for multiple comparisons was 
applied using the Benjamini-Hochberg procedure and a false discovery rate of 0.05 was chosen. Adjusted p value: 0.070 
for maternal smoking during pregnancy. a Metabolic syndrome was defined by the International Diabetes Federation as 
having central obesity measured by waist circumference or BMI, together with any two of the following components: 
(1) raised triglycerides; (2) reduced HDL cholesterol; (3) raised blood pressure; and (4) raised fasting plasma glucose. b 
Growth data at 2.5 years: uncorrected for prematurity. c Maternal education and socioeconomic status (SES) were 
collected using parent questionnaire at age 2.5 years; SES was based on using parent occupation: (1) higher: non-
manual employment; (2) lower: including those in manual employment or unemployed.   
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Table 3 Multivariate linear regression: BMI and central systolic blood pressure (SBP) at 19 years as 
dependent variables in young adults born extremely preterm +  
 
BMI (kg/m2) Central SBP (mmHg) 
β (95%CI) Ꞁ p β (95%CI) Ꞁ P 
Birthweight z-score (SD) -0.54 (-1.58, 0.50) 0.305 -0.69 (-2.49, 1.11) 0.448 
∆ weight z-score from birth to term-age (SD) 0.30 (-0.46, 1.06) 0.438 0.08 (-1.28, 1.44) 0.907 
∆ weight z-score from term-age to 2.5y (SD) 0.18 (-0.33, 0.69) 0.482 0.19 (-0.74, 1.12) 0.687 
∆ weight z-score from 2.5y to 6y (SD) 1.03 (0.31, 1.75) 0.006* 1.75 (0.48, 3.02) 0.007* 
∆ weight z-score from 6y to 11y (SD) 0.98 (0.02, 1.93) 0.046 0.13 (-1.60, 1.86) 0.882 
+Adjusted for sex, maternal age, and maternal smoking during pregnancy. Ꞁ β presents the average change in BMI and 
central SBP for per SD change in birth weight z-scores or in ∆ weight z-scores in different periods. *Correction for 
multiple comparisons was applied using the Benjamini-Hochberg procedure and a false discovery rate of 0.05 was 
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-1.90 (-3.35, -0.45) 
Figure 1 Size at birth, growth trajectory in early life and BMI in early adulthood  
Note: ns represents not significant; birthweight z-scores were derived from the complete birth population29. 
Socioeconomic status (SES) was collected using parent questionnaire at age 2.5 years and was based on using 
parent occupation: (1) higher: non-manual employment; (2) lower: including those in manual employment or 
unemployed. 
 Figure 2 Size at birth, growth trajectory in early life and central SBP in early adulthood  
Note: ns represents not significant; SBP represents systolic blood pressure. 
 
Birth 




∆ weight  z-score 
∆ weight  z-score 
∆ weight  z-score 
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Assessed at 2.5 
years 
Assessed at 6 
years 
Assessed at 11 
years 
Assessed at 19 
years 
N=315 N=283 N=241 N=219 N=129 
Male Sex 
% (n)                     
49.2% 
(155) 
47.7% (135) 50.6% (122) 46.1% (101) 47.3% (61) 
Gestational age       
<=23 weeks  % (n)                     9.2% (29) 9.2% (26) 10.0% (24) 10.5% (23) 11.6% (15) 
24 weeks 
% (n)                     
31.7% 
(100) 





59.0% (167) 59.8% (144) 57.5% (126) 59.7% (77) 
Multiple births % (n/N)                     
25.2% 
(79/314) 
26.9% (76/283) 26.1% (63/241) 28.0% (61/218) 31.3% (40/128) 
White ethnicity % (n)                     
76.5% 
(241) 












29.2 (5.6) [n=127] 
Maternal smoking during pregnancy % (n/N)                     
32.9% 
(93/283) 
33.2% (93/280) 32.3% (76/235) 33.8% (72/213) 25.6% (33/129) 
Maternal education (A level or 
above)+ 
% (n/N)                     
25.9% 
(68/263) 
25.9% (68/263) 23.6% (52/220) 24.0% (48/200) 27.3% (33/121) 
Higher SES + % (n/N)                     
31.0% 
(84/271) 
31.0% (84/271) 32.2% (73/227) 32.9% (68/207) 44.3% (54/122) 











-0.18 (0.77) [n=281] 
-0.18 (0.75) 
[n=239] 
-0.15 (0.79) [n=216] -0.22 (0.76) [n=126] 
+ Maternal education and SES were collected using parent questionnaire at age 2.5 years. Socioeconomic status (SES) was based on using parent occupation: (1) higher: 
non-manual employment; (2) lower: including those in manual employment or unemployed. 
Figure S1 Birth weight for gestational age and BMI stratified by socioeconomic status (SES)
 
